GM 10395
Alternative Names: GM-10395Latest Information Update: 12 Dec 2022
Price :
$50 *
At a glance
- Originator JD BIOSCIENCE
- Class Anti-inflammatories; Antineoplastics; Small molecules
- Mechanism of Action Pyruvate dehydrogenase kinase modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Preclinical Cancer; Inflammation
Most Recent Events
- 09 Dec 2022 Preclinical trials in Cancer in South Korea (unspecified route) (JD BIOSCIENCE pipeline, December 2022)
- 09 Dec 2022 Preclinical trials in Inflammation in South Korea (unspecified route) (JD BIOSCIENCE pipeline, December 2022)
- 10 Jun 2022 GM 10395 is available for licensing as of 10 Jun 2022. http://jdbiosci.com/sub_collabo.php